Sreekanth Gattu

Sreekanth Gattu, MD, MSc, MPM, currently serves as a Visiting Professor at Sri Ramachandra Medical College and Research Institute, where Sreekanth delivers guest lectures on drug development in the Department of Pharmacology. With extensive experience in the pharmaceutical industry, Sreekanth holds the position of Global Program Head at Sandoz, overseeing the development of biosimilars in Oncology and Neurology, and has held multiple leadership roles focused on clinical development of immuno-oncology and neurology biosimilars. Previous positions include roles at Novartis, where Sreekanth launched a digital project to enhance clinical development decisions using AI, and served as an Associate Director in Global Development. Sreekanth founded Path2Pharma, an initiative supporting aspiring pharmaceutical physicians in India, and possesses a robust educational background with degrees from institutions such as Ulm University and Harvard Kennedy School.